Wesana Health CEO Daniel Carcillo to Speak at Several Leading Investor and Industry Events

Rhea-AI Summary

Wesana Health Holdings Inc. (CSE: WESA; OTCQB: WSNAF) announces CEO Daniel Carcillo will speak at various investor events. Key conferences include the Benzinga Psychedelics Capital Conference and NobleCon 18, both happening in Miami on April 19-21, as well as the Psychedelic Therapeutics & Drug Development Conference in Washington, DC, on May 23-24. Carcillo emphasized the importance of engaging with stakeholders about the company's novel drug development program and FDA interactions, highlighting their path to regulatory approval.

CHICAGO and TORONTO, March 29, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care paradigms today, is pleased to confirm CEO Daniel Carcillo will be speaking at several investor and industry events over the coming weeks.

Mr. Carcillo will be speaking at:

Benzinga Psychedelics Capital Conference, Miami, April 19

Noble Capital Markets’ NobleCon 18, Miami, April 19-21

The Psychedelic Therapeutics & Drug Development Conference, Washington, DC, May 23-24

“We are excited to update investors regarding Wesana’s most recent interactions with the FDA. Connecting with key stakeholders and community members about our novel drug development program and the defined pathway forward to regulatory approval is incredibly important to us,” said Mr. Carcillo.

To find out more or to arrange a meeting with Mr. Carcillo, please contact Keenan Gentry, Vice President Investor Relations & Corporate Development at Wesana via email, at IR@wesanahealth.com.

About Wesana Health

Wesana Health helps people transcend barriers in mental health and performance. We innovate in care development through our therapies and patent-pending protocols, and in care delivery through activating a new multidisciplinary, technology-supported clinical model. Learn more at www.wesanahealth.com.

Investor Relations:
Keenan Gentry
Email: IR@wesanahealth.com
Phone: 702-329-8038

Media Contacts:
Isadora Forman
Email: media@wesanahealth.com 
Phone: 917-653-4613

FAQ

What events will Wesana Health's CEO speak at in April 2022?

CEO Daniel Carcillo will speak at the Benzinga Psychedelics Capital Conference and NobleCon 18 in Miami from April 19-21.

When is the Psychedelic Therapeutics & Drug Development Conference?

The Psychedelic Therapeutics & Drug Development Conference is scheduled for May 23-24, 2022, in Washington, DC.

What is the focus of Wesana Health Holdings Inc.?

Wesana Health focuses on developing novel therapies and new care paradigms for mental health and performance challenges.

What regulatory updates has Wesana Health provided?

Wesana Health is engaging with stakeholders about their drug development program and interactions with the FDA for regulatory approval.

How can I contact Wesana Health for investor relations?

Investors can contact Keenan Gentry at IR@wesanahealth.com for inquiries.